Zidovudine
Synonym(s)
DefinitionThis section has been translated automatically.
Half-lifeThis section has been translated automatically.
Pharmacodynamics (Effect)This section has been translated automatically.
IndicationThis section has been translated automatically.
Pregnancy/nursing periodThis section has been translated automatically.
Dosage and method of useThis section has been translated automatically.
- Peroral application (cps/filmbl./sg.): Adults: 500-600 mg/day divided into 2-3 EDs. Children > 3 months - 12 years 360-480 mg/m2 KO/day divided into 3-4 ED.
- I.v. application: adults (70 kg): 1 or 2 mg/kg bw every 4 hours, children: 80-160 mg/m2 KO every 6 hours i.v.
- Infants > 3 months: 12 mg/kg bw/day
- infants < 3 months: 8 mg/kg bw/day
Remember! Men should not conceive children during AZT treatment and up to 6 months (e.g. as part of post-exposure prophylaxis) afterwards!
Undesirable effectsThis section has been translated automatically.
- Cutaneous ADRs: erythroderma, maculopapular exanthema, urticaria, nail pigmentation.
- Also: anemia, neutropenia, leukopenia, gastrointestinal problems, fever, headache, reaction limitation, paresthesias, proximal myopathies in long-term use.
Notice! Increase of side effects with simultaneous administration of Cotrimoxazole and Pyrimethamine
. Simultaneous administration of ganciclovir almost always results in myelosuppression, which can be corrected by administration of G-CSF!
InteractionsThis section has been translated automatically.
ContraindicationThis section has been translated automatically.
PreparationsThis section has been translated automatically.
Note(s)This section has been translated automatically.
TablesThis section has been translated automatically.
Main interactions of zidovudine
Acetylsalicylic acid |
Zidovudine toxicity ↑ |
Aciclovir |
rarely seizures ↑ |
amphotericin B |
Haematotoxicity ↑ |
Anti-inflammatories, non-steroidal |
Zidovudine toxicity ↑ |
Atovaquon |
Zidovudine plasma levels ↑ by 35% |
Barbiturates |
Zidovudine toxicity ↑ |
Cotrimoxazole |
Myelosuppression ↑ |
Dapson |
Myelosuppression ↑ |
Doxorubicin |
Myelosuppression ↑ |
Etoposide |
Myelosuppression ↑ |
Fluconazole |
Zidovudine plasma mirror ↑ |
Flucytosine |
Haematotoxicity ↑ |
Foscarnet |
Anemia |
Ganciclovir |
Haematotoxicity ↑, avoid combination |
Levomethadone |
Zidovudine plasma mirror ↑ |
Pentamidine i.v. |
rarely hematotoxicity ↑ |
Ribavirin |
Ribavirin effect ↓ |
Rifabutin |
Zidovudine plasma mirror ↓ |
Sulfonamides |
Haematotoxicity ↑ |
Vinblastine |
Haematotoxicity ↑ |
Vincrist |
Haematotoxicity ↑ |